Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2017. Start Trial.
Date Value
November 20, 2026 1.506B
November 19, 2026 1.529B
November 18, 2026 1.518B
November 17, 2026 1.475B
November 16, 2026 1.479B
November 13, 2026 1.494B
November 12, 2026 1.540B
November 11, 2026 1.570B
November 10, 2026 1.558B
November 09, 2026 1.546B
November 06, 2026 1.500B
November 05, 2026 1.474B
November 04, 2026 1.532B
November 03, 2026 1.538B
November 02, 2026 1.514B
October 30, 2026 1.555B
October 29, 2026 1.566B
October 28, 2026 1.621B
October 27, 2026 1.595B
October 26, 2026 1.570B
October 23, 2026 1.568B
October 22, 2026 1.550B
October 21, 2026 1.545B
October 20, 2026 1.470B
October 19, 2026 1.584B
Date Value
October 16, 2026 1.505B
October 15, 2026 1.568B
October 14, 2026 1.507B
October 13, 2026 1.474B
October 12, 2026 1.488B
October 09, 2026 1.485B
October 08, 2026 1.493B
October 07, 2026 1.476B
October 06, 2026 1.543B
October 05, 2026 1.582B
October 02, 2026 1.562B
October 01, 2026 1.565B
September 30, 2026 1.614B
September 29, 2026 1.603B
September 28, 2026 1.616B
September 25, 2026 1.622B
September 24, 2026 1.642B
September 23, 2026 1.615B
September 22, 2026 1.708B
September 21, 2026 1.738B
September 18, 2026 1.746B
September 17, 2026 1.742B
September 16, 2026 1.720B
September 15, 2026 1.731B
September 14, 2026 1.714B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Agenus, Inc. 453.57M
Amgen, Inc. 276.45B
Anika Therapeutics, Inc. 158.39M
BioCryst Pharmaceuticals, Inc. 2.302B
Imunon, Inc. 6.224M